"This particular record has played itself out many times before at FDA."
- Mark Gardner, head of product management for the genetic systems division at Life Technologies Corp., on the FDA's need to develop new regulations for new technologies, such as lab-developed tests
"After a decade, genomics gave us a lot of drug targets. But it stopped there."
- Leerink Swann analyst John …

Комментариев нет:
Отправить комментарий